Home Cart 0 Sign in  
X

[ CAS No. 6482-24-2 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 6482-24-2
Chemical Structure| 6482-24-2
Chemical Structure| 6482-24-2
Structure of 6482-24-2 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 6482-24-2 ]

Related Doc. of [ 6482-24-2 ]

Alternatived Products of [ 6482-24-2 ]
Product Citations

Product Details of [ 6482-24-2 ]

CAS No. :6482-24-2 MDL No. :MFCD00000236
Formula : C3H7BrO Boiling Point : -
Linear Structure Formula :CH3OCH2CH2Br InChI Key :YZUPZGFPHUVJKC-UHFFFAOYSA-N
M.W : 138.99 Pubchem ID :80972
Synonyms :

Calculated chemistry of [ 6482-24-2 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 5
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 25.49
TPSA : 9.23 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.55 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.88
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 1.03
Log Po/w (MLOGP) : 0.96
Log Po/w (SILICOS-IT) : 0.93
Consensus Log Po/w : 1.13

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 3.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.1
Solubility : 11.1 mg/ml ; 0.0796 mol/l
Class : Very soluble
Log S (Ali) : -0.62
Solubility : 33.6 mg/ml ; 0.242 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -1.64
Solubility : 3.18 mg/ml ; 0.0229 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.86

Safety of [ 6482-24-2 ]

Signal Word:Danger Class:3,6.1
Precautionary Statements:P210-P301+P310+P330-P302+P352-P305+P351+P338 UN#:1992
Hazard Statements:H226-H301-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 6482-24-2 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 6482-24-2 ]
  • Downstream synthetic route of [ 6482-24-2 ]

[ 6482-24-2 ] Synthesis Path-Upstream   1~26

  • 1
  • [ 110-85-0 ]
  • [ 6482-24-2 ]
  • [ 13484-40-7 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1993, vol. 41, # 1, p. 148 - 155
  • 2
  • [ 109-86-4 ]
  • [ 6482-24-2 ]
Reference: [1] Patent: WO2006/64897, 2006, A1, . Location in patent: Page/Page column 7-8
[2] Patent: WO2006/64897, 2006, A1, . Location in patent: Page/Page column 10
[3] Chemische Berichte, 1931, vol. 64, p. 798
[4] Candad.J.Res., 1932, vol. 7, p. 467[5] Chem. Zentralbl., 1933, vol. 104, # I, p. 1758
[6] Journal of Organic Chemistry, 1962, vol. 27, p. 806 - 814
[7] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, p. 1303 - 1310
[8] Synthesis, 2002, # 4, p. 479 - 482
[9] Patent: WO2006/64897, 2006, A1, . Location in patent: Page/Page column 8; 1/1
[10] Molecules, 2013, vol. 18, # 1, p. 50 - 73
[11] Patent: US2014/221495, 2014, A1, . Location in patent: Paragraph 0027
  • 3
  • [ 77-78-1 ]
  • [ 540-51-2 ]
  • [ 6482-24-2 ]
Reference: [1] Journal of the American Chemical Society, 1945, vol. 67, p. 290,292
  • 4
  • [ 67-56-1 ]
  • [ 74-85-1 ]
  • [ 6482-24-2 ]
Reference: [1] Journal of the American Chemical Society, 1978, vol. 100, p. 3506 - 3513
[2] Bulletin de la Societe Chimique de France, 1970, p. 2432 - 2439
  • 5
  • [ 110-71-4 ]
  • [ 123-91-1 ]
  • [ 6482-24-2 ]
Reference: [1] Polyhedron, 2011, vol. 30, # 8, p. 1412 - 1419
  • 6
  • [ 110-71-4 ]
  • [ 123-91-1 ]
  • [ 106-93-4 ]
  • [ 6482-24-2 ]
Reference: [1] Polyhedron, 2011, vol. 30, # 8, p. 1412 - 1419
  • 7
  • [ 17178-10-8 ]
  • [ 6482-24-2 ]
Reference: [1] Organic Process Research and Development, 2007, vol. 11, # 3, p. 468 - 469
  • 8
  • [ 1273390-27-4 ]
  • [ 123-91-1 ]
  • [ 6482-24-2 ]
Reference: [1] Polyhedron, 2011, vol. 30, # 8, p. 1412 - 1419
  • 9
  • [ 4296-15-5 ]
  • [ 6482-24-2 ]
Reference: [1] Chem. Zentralbl., 1912, vol. 83, # II, p. 1269
  • 10
  • [ 124-41-4 ]
  • [ 106-93-4 ]
  • [ 6482-24-2 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1983, p. 1303 - 1310
  • 11
  • [ 2615-15-8 ]
  • [ 6482-24-2 ]
  • [ 4437-01-8 ]
YieldReaction ConditionsOperation in experiment
41% With sodium hydride In tetrahydrofuran at 20℃; for 2 h; To a solution of hexa(ethylene glycol)(10 g, 35 mmole) and 2-bromoethyl methyl ether (4.9 g, 35 mmole) in THF (100 mL) was slowly added sodium hydride (2.55 g, 106 mmole). The solution was stirred at room temperature for two hours. HPLC indicated that mPEG7-OH was formed in about 54percent yield. The reaction was then stopped by the addition of diluted hydrochloride acid to destroy excess sodium hydride. All solvents were removed using a rotary evaporator to give a brown sticky liquid. Pure mPEG7-OH was obtained as a colorless liquid (4.9 g, 41percent isolated yield) by using semi-preparative HPLC (20 cm.x.4 cm, C18 column, acetonitrile and water as mobile phases). 1H NMR (CDCl3): 2.57 ppm (triplet, 1 H, OH); 3.38 ppm (singlet, 3 H, CH3O); 3.62 ppm (multiplet, 30 H, OCH2CH2).
Reference: [1] Patent: US2005/136031, 2005, A1, . Location in patent: Page/Page column 25
  • 12
  • [ 112-60-7 ]
  • [ 6482-24-2 ]
  • [ 23778-52-1 ]
YieldReaction ConditionsOperation in experiment
35%
Stage #1: With potassium <i>tert</i>-butylate In tetrahydrofuran at 20℃; for 0.5 h;
Stage #2: at 20℃;
Tetra(ethylene glycol) (55 mmol, 10.7 g) was dissolved in 100 mL of tetrahydrofuran ("THF") and to this solution was added KOtBu (55 mL, 1.0 M in THF) at room temperature. The resulting solution was stirred at room temperature for 30 minutes, followed by dropwise addition of CH3OCH2CH2Br (55 mmol, 5.17 mL in 50 mL THF). The reaction was stirred at room temperature overnight, followed by extraction with H2O (300 mL)/CH2Cl2 (3.x.300 mL). The organic extracts were combined and then dried over anhydrous Na2SO4. After filtering off the solid drying agent and removing the solvent by evaporation, the recovered crude residue was purified by column chromatography using a silica gel column (CH2Cl2:CH3OH=60:140:1) to give pure penta(ethylene glycol) monomethyl ether (yield 35percent). 1H NMR (CDCl3) δ 3.75-3.42 (m, 20 H, OCH2CH2O), 3.39 (s, 3H, MeO).
Reference: [1] Patent: US2005/136031, 2005, A1, . Location in patent: Page/Page column 25
  • 13
  • [ 100-02-7 ]
  • [ 6482-24-2 ]
  • [ 22483-40-5 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In N,N-dimethyl-formamide at 80℃; for 5 h; [00546] To a solution of 4-nitrophenol (2.78 g, 20 mmol) and 2-bromoethyl methyl ether (3.6 g,26 mmol) in DMF (10 mL) were added K2C03 (5.52 g, 40 mmol) and the reaction was stirred at80°C for 5 h. The mixture was cooled down tort and then quenched with H20 (30 mL) andEtOAc ( 40 mL ). The layers were separated and the aqueous layer was extracted with EtOAc (2x 25 mL). The combined organic extracts were washed with brine (2 x 20 mL), dried (Na2S04)and concentrated to afford 1-(2-methoxyethoxy)-4-nitrobenzene (38) (3.9 g, 100percent) as a yellowsolid.
97.6% With potassium carbonate In N,N-dimethyl-formamide at 65 - 70℃; for 4 h; To a solution of 4-nitrophenol (18.2 g, 130 mmol) and 1-bromo-2-methoxyethane (20 g, 144 mmol) in DMF (60 ml), K2CO3 (36 g, 260 mmol) was added. The reaction mixture was stirred at 65~70°C for 4 h and then cooled to room temperature. Water (200 mL) was added and the mixture was extracted with ethyl acetate (200 mL x3). The combined organic layers were washed with water (200 ml x3), dried over Na2SO4. The solvent was removed under reduced pressure to yield the desired product (3) as white solid (25 g, 97.6percent yield), which was used for the next step without further purification.
Reference: [1] Patent: WO2014/130693, 2014, A1, . Location in patent: Paragraph 00544; 00546
[2] Patent: WO2015/6754, 2015, A2, . Location in patent: Paragraph 00243; 00244
[3] European Journal of Medicinal Chemistry, 1980, vol. 15, # 5, p. 399 - 404
[4] Patent: US2005/277668, 2005, A1, . Location in patent: Page/Page column 17
  • 14
  • [ 100-02-7 ]
  • [ 70384-51-9 ]
  • [ 584-08-7 ]
  • [ 6482-24-2 ]
  • [ 22483-40-5 ]
Reference: [1] Patent: US5585394, 1996, A,
  • 15
  • [ 1124-31-8 ]
  • [ 6482-24-2 ]
  • [ 22483-40-5 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1941, vol. &lt;2&gt;158, p. 266,272
  • 16
  • [ 591-27-5 ]
  • [ 6482-24-2 ]
  • [ 110178-35-3 ]
Reference: [1] Patent: US2003/195201, 2003, A1,
  • 17
  • [ 603-35-0 ]
  • [ 6482-24-2 ]
  • [ 55894-16-1 ]
YieldReaction ConditionsOperation in experiment
78% for 24 h; Heating / reflux EXAMPLES; a) 2-(l-pyrrolidino)-ethyl triphenyl phosphonium bromide is obtained by refluxing Triphenyl phosphine (300 gm, 1.14 mole) and 2-methoxy ethyl bromide (2QQgni, 1.43 rnole) in toluene (1 It) for 24 hours. Reaction mass was then cooled to 3O0C and filtered to obtain 2-Methoxy ethyl triphenyl phosphonium bromide (450gm, 78percent) which is further reacted <n="7"/>with pyrrolidine (96gm, 1.37 mole) in methanol (500ml) at 60 C for 2 hours. Distilled off methanol and the solid obtained was suspended in toluene (lit), then cooled to 300C and filtered to obtain 2-(l-pyrrolidino)- ethyl triphenyl phosphonium bromide (450gm, 91percent). NMR (D2O) δ : 1.67 (m,4H), 2.46 (m,4H), 2.78 (m,2H), 3.41 (m,2H), 7.68 (m, 15H)
Reference: [1] Tetrahedron Letters, 2008, vol. 49, # 5, p. 824 - 826
[2] Patent: WO2007/141803, 2007, A2, . Location in patent: Page/Page column 5-6
  • 18
  • [ 106-41-2 ]
  • [ 6482-24-2 ]
  • [ 39255-23-7 ]
YieldReaction ConditionsOperation in experiment
96% With potassium carbonate In N,N-dimethyl-formamide at 60℃; General procedure: K2CO3 (18 mmol, 2.5 g) was suspended in 15 mL of DMF. The phenol (6.0 mmol) and the alkyl halide (6.6 mmol) were added subsequentially and the suspension was stirred overnight at 60 °C. The reaction mixture was diluted with 50 mL demiwater and the resulting reaction mixture was extracted with with EtOAc (3 x 30 mL). The combined organic layers were, washed with brine (1 x 50 mL), dried over Na2SO4 and filtered. The solvent was evaporated under reduced pressure to give the product in high purity.
48% With potassium carbonate In N,N-dimethyl-formamide at 20℃; Step 1-Preparation 1-Bromo-4-(2-methoxy-ethoxy)-benzene (42)To a solution of 4-bromophenol (41, 5.0 g, 28.9 mmol) in dimethylformamide (15 mL) were added potassium carbonate (4.40 g, 31.8 mmol) and 1-bromo-2-methoxyethane (5.00 g, 36.0 mmol) under an atmosphere of nitrogen. The reaction mixture was stirred at ambient temperature overnight and concentrated under reduced pressure. The residue was slurried in ethyl acetate (50 mL) and filtered. The filtrate was washed with saturated sodium bicarbonate solution, dried over magnesium sulfate and filtered. Silica gel column chromatography (0-10percent ethyl acetate in hexanes) gave the desired compound as a colorless oil (42, 3.2 g, 48percent).
48% With potassium carbonate In N,N-dimethyl-formamide at 20℃; To a solution of 4-bromophenol (646, 5.0 g, 28.9 mmol) in dimethylformamide (15 mL) were added potassium carbonate (4.40 g, 31.8 mmol) and l-bromo-2-methoxyethane (5.00 g, 36.0 mmol) under an atmosphere of nitrogen. The reaction mixture was stirred at ambient temperature overnight and concentrated under reduced pressure. The residue was slurried in ethyl acetate (50 mL) and filtered. The filtrate was washed with saturated sodium bicarbonate solution, dried over magnesium sulfate and filtered. Silica gel column chromatography (0-10percent ethyl acetate in hexanes) gave the desired compound as a colorless oil (647, 3.2 g, 48percent).
Reference: [1] European Journal of Medicinal Chemistry, 2012, vol. 47, # 1, p. 337 - 344
[2] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 6, p. 1659 - 1662
[3] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 16, p. 3670 - 3674
[4] Patent: US2008/167338, 2008, A1, . Location in patent: Page/Page column 41
[5] Patent: WO2007/2325, 2007, A1, . Location in patent: Page/Page column 216
[6] Bulletin of the Chemical Society of Japan, 1997, vol. 70, # 10, p. 2519 - 2523
[7] Patent: US2005/209278, 2005, A1,
[8] Patent: US2005/9838, 2005, A1, . Location in patent: Page 130
  • 19
  • [ 6482-24-2 ]
  • [ 139-85-5 ]
  • [ 80407-64-3 ]
YieldReaction ConditionsOperation in experiment
98% With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 2 h; a) 3,4-bis (2-methoxyethoxy) benzaldehyde:; To 3, 4-dihydroxy benzaldehyde of the formula Il (25g, 0.1811 mole), potassium carbonate (6Og, 0.4347 mole) in N, N-dimethyl formamide (120ml) was added 2-bromoethylmethyl ether (50.4g, 0.3625 mole). The mixture was stirred at 1000C for 2 hours, cooled to room temperature, filtered inorganics. The clear filtrate was concentrated under vacuum and the residue was dissolved in methylene chloride, washed with water and dried over calcium chloride. ^Evaporation yielded 3,4-bis (2-methoxyethoxy) benzaldehyde of formula III (45g, 98percent).NMR spectrum (CDCI3): δ 3.46 (s, 6H), 3.81 (m, 4H), 4.22 (m, 4H), 7.00(d, 1 H), 7.43(s, 1 H), 7.45(d, 1 H) and 9.83(s, 1 H).
98% With potassium carbonate In N,N-dimethyl-formamide at 100℃; for 2 h; a) 3,4-bis (2-methoxyethoxy) benzaldehyde:; To 3, 4-dihydroxy benzaldehyde of the formula Il (25g, 0.1811 mole), potassium carbonate (6Og, 0.4347 mole) in N, N-dmethyl formamide (120ml) was added 2-bromoethylmethyl ether (50.4g, 0.3625 mole). The mixture was stirred at 1000C for 2 hours, cooled to room temperature, filtered inorganics. The clear filtrate was concentrated under vacuum and the residue was dissolved in methylene chloride, washed with water and dried over calcium chloride. Evaporation yielded 3,4-bis (2- methoxyethoxy) benzaldehyde of formula III (45g, 98percent).NMR spectrum (CDCI3): δ 3.46 (s, 6H), 3.81 (m, 4H), 4.22 (m, 4H), 7.00(d, 1 H), 7.43(S1 1H)1 7.45(d, 1 H) and 9.83(s, 1 H).
Reference: [1] Heterocycles, 2007, vol. 71, # 1, p. 39 - 48
[2] Patent: WO2007/138612, 2007, A2, . Location in patent: Page/Page column 9
[3] Patent: WO2007/138613, 2007, A2, . Location in patent: Page/Page column 10
[4] Organic Letters, 2017, vol. 19, # 11, p. 3005 - 3008
  • 20
  • [ 3943-89-3 ]
  • [ 6482-24-2 ]
  • [ 183322-16-9 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate; potassium iodide In acetone at 60℃; for 19 h; Inert atmosphere (3)
Preparation of Ethyl 3,4-dimethoxyethoxybenzoate 13
Ethyl 3,4-dihydroxy benzoate 12 (5 g, 27.45 mmol) is placed in a two-neck bottle of 250 ml, N2 is added at room temperature, and acetone (100 ml), potassium carbonate (9.48 g, 68.63 mmol), potassium iodide (0.5 g) and 2-Bromoethyl methyl ether (7.84 ml, 82.35 mmol) are added.
Then heat refluxing is carried out at 60° C. for 19 hours.
After the reaction is completed, the resultant of reaction is cooled at 5° C. and stirred for 30 minutes, then filtered and concentrated to dry.
The solid is dried by oil-less pump for 22 hours to obtain khaki compound 13 (8.19 g, 100percent).
1H-NMR (CDCl3) spectrum: 1.32 (t, 3H, J=7 Hz), 3.41 (s, 6H), 3.76 (m, 4H), 4.15 (m, 4H), 4.29 (q, 2H, J=7 Hz), 6.85 (d, 1H, J=8.4 Hz), 7.53 (dd, 1H, J=8.4 Hz, J=2.3 Hz), 7.53 (m, 1H), 7.63 (dd, 1H, J=8.4 Hz, J=2.3 Hz).
93% With potassium carbonate In acetone at 20 - 70℃; for 24 h; 3,4-Dihydroxy-benzoic acid ethyl ester (compound A') (2.0 g) was dissolved in acetone (20 ml). Potassium carbonate (4.3 g) and 1-bromo-2-methoxy-ethane (compound D) (5 ml) were added to the solution at room temperature, and the mixture was then stirred at 70°C for 24 hr. After the completion of the reaction, the reaction solution was allowed to stand for cooling at room temperature, and the reaction system was concentrated under the reduced pressure. Distilled water was added to the residue, and the mixture was then subjected to separatory extraction with chloroform. The organic layer was washed with saturated brine, was dried over sodium sulfate, and was then concentrated under the reduced pressure. The residue was purified by column chromatography using a hexane-acetone system to give 3,4-bis-(2-methoxy-ethoxy)-benzoic acid ethyl ester (3.06 g, yield 93percent).
93% With tetra-(n-butyl)ammonium iodide; potassium carbonate In acetone for 64 h; Inert atmosphere; Reflux To ethyl 3,4-dihydroxybenzoate (36.4 g, 0.200 mol), K2CO3 (60.8 g, 0.44 mol) and tetrabutylammonium iodide(750 mg) in degassed acetone (400 mL) was added 2-bromoethyl methyl ether (69.5 g, 47 mL). The mixture was stirred under N2 at reflux for 64 hours. Ether (600 mL) was added to the mixture and after stirring 30 minutes at 20 °C theprecipitated salts were removed by filtration. The filtrate was concentrated in vacuo and the residue was triturated withhexane (500 mL) for 30 minutes and the white solid ethyl 3,4-bis(2-methoxy-ethoxy)benzoate was filtered and dried invacuo (55.5 g; 93percent; M.P. 50-51 °C). A portion of this product (45.7 g, 0.158 mol) in acetic acid (150 mL) was treateddropwise with conc. HNO3 (40 mL) at 5°C and the solution stirred 24 hours before pouring into cold H2O (1.6 L). Themixture was extracted with ethyl acetate (1.1 L), and the organic phase was washed three times with 200 mL H2O, andbrine, dried over Na2SO4, filtered and concentrated in vacuo to afford ethyl 4,5-bis-(2-methoxy-ethoxy)-2-nitro-benzoate(54.3 g) as a brown oil. This nitro product (52.0 g, 0.15 mol) was dissolved in ethanol (1000 mL) containing 1 equivalentof HCl (generated in the ethanol by prior addition of 11 mL acetyl chloride), PtO2•H2O (1.0 g) was added, and the mixturewas hydrogenated under 45 psi H2 for 6 hours. The catalyst was removed by filtration through Celite, and the filtratewas concentrated in vacuo to a thick slurry which was diluted with ether (400 mL). The solid white hydrochloride salt ofethyl 2-amino-4,5-bis-(2-methoxy-ethoxy)benzoate was filtered and dried in vacuo (44.7 g; 88percent). A portion of this material(42 g, 0.12 mol) and ammonium formate (7.6 g, 0.12 mol) were disssolved in formamide (63 mL) and the stirred mixturewas heated to 160-165 °C under an atmosphere of N2 for 3 hours. H2O (200 mL) was added and after cooling theprecipitated crude title product was recovered by filtration, washed with cold H2O, and dried in vacuo. The filtrate wasextracted five times with CHCl3, and the pooled organic extracts were washed with brine, dried over Na2SO4, andconcentrated in vacuo. The residue and crude quinazolone precipitate were combined, triturated in hot acetonitrile (250mL) for 30 minutes, cooled to 20 °C and treated with ether (250 mL). After cooling to 4 °C the white solid was filteredand dried in vacuo (30.4 g, 86percent; GC-MS m/z 294 (M+)).
Reference: [1] Patent: US2010/267949, 2010, A1, . Location in patent: Page/Page column 6
[2] Patent: EP1614676, 2006, A1, . Location in patent: Page/Page column 194
[3] Patent: EP2163546, 2016, B1, . Location in patent: Paragraph 0125
[4] European Journal of Medicinal Chemistry, 2008, vol. 43, # 7, p. 1478 - 1488
[5] Chemistry - A European Journal, 2015, vol. 21, # 41, p. 14342 - 14346
[6] Journal of Labelled Compounds and Radiopharmaceuticals, 2005, vol. 48, # 11, p. 829 - 843
[7] Molecules, 2006, vol. 11, # 4, p. 286 - 297
[8] European Journal of Medicinal Chemistry, 2013, vol. 67, p. 293 - 301
[9] Journal of Labelled Compounds and Radiopharmaceuticals, 2018, vol. 61, # 2, p. 42 - 53
  • 21
  • [ 3943-89-3 ]
  • [ 6482-24-2 ]
  • [ 183322-16-9 ]
Reference: [1] Patent: US5821246, 1998, A,
  • 22
  • [ 6482-24-2 ]
  • [ 2096-10-8 ]
  • [ 473278-54-5 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2008, vol. 27, # 9, p. 1024 - 1033
  • 23
  • [ 269410-08-4 ]
  • [ 6482-24-2 ]
  • [ 847818-71-7 ]
YieldReaction ConditionsOperation in experiment
90% With potassium carbonate In N,N-dimethyl-formamide at 160℃; for 2 h; Microwave irradiation A mixture of 4-(4,4,5 ,5 -tetramethyl- 1,3 ,2-dioxaborolan-2-yl)- 1H-pyrazole (1.94 g, 10 mmol), 2-bromoethyl methyl ether (1.68 g, 12 mmol) and K2C03 (2.76 g, 20 mmol) in DMF (16 mL) was stirred at 160 °C for 2 h in the microwave. The reaction mixture was concentrated and purified by silica gel chromatography (30percent EA:PE) to give 2.2 g (90percent) of the title compound as yellow oil. ‘H NMR (400 MHz, CDC13): ö 1.32 (12H, s), 3.32 (3H, s), 3.75 (2H, t, J= 5.2 Hz), 4.30 (2H, t, J= 5.2 Hz), 7.77 (1H, s), 7.79 (1H, s). [M+H] Calc’d for C,2H2,BN203, 253; Found, 253.
68% With caesium carbonate In N,N-dimethyl-formamide at 150℃; for 0.5 h; Microwave irradiation Example A68Preparation of intermediate 68: l-(2-Methoxy-ethyl)-4-(4,4,5,5-tetramethyl- [l,3,21dioxaborolan-2-yl)-7H-pyrazoleA mixture of 4-(4,4,5,5-tetramethyl-[l,3,2]dioxaborolan-2-yl)-7H-pyrazole (1 g, 5.15 mmol), 2-bromoethyl methyl ether (0.63 ml, 6.7 mmol) and cesium carbonate (2.52 g, 7.73 mmol) in N,N-dimethylformamide (7 ml) was stirred at 150 °C for 30 min. under microwave irradiation. The mixture was partitioned between water and diethyl ether. The organic layer was separated, dried (Na2S04), filtered and the solvents evaporated in vacuo. The crude product was purified by flash column chromatography (silica; ethyl acetate in heptane 30/70). The desired fractions were collected and concentrated in vacuo to yield intermediate 68 (0.88 g, 68percent) as a pale yellow oil.
68% With caesium carbonate In N,N-dimethyl-formamide at 150℃; for 0.5 h; microwave irradiation Example A68
Preparation of intermediate 68: 1-(2-Methoxy-ethyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole
A mixture of 4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-pyrazole (1 g, 5.15 mmol), 2-bromoethyl methyl ether (0.63 ml, 6.7 mmol) and cesium carbonate (2.52 g, 7.73 mmol) in N,N-dimethylformamide (7 ml) was stirred at 150° C. for 30 min. under microwave irradiation.
The mixture was partitioned between water and diethyl ether.
The organic layer was separated, dried (Na2SO4), filtered and the solvents evaporated in vacuo.
The crude product was purified by flash column chromatography (silica; ethyl acetate in heptane 30/70).
The desired fractions were collected and concentrated in vacuo to yield intermediate 68 (0.88 g, 68percent) as a pale yellow oil.
57% With caesium carbonate In N,N-dimethyl-formamide at 0 - 20℃; 2-Bromoethyl methyl ether (0.93 g, 6.70 mmol, 0.64 mL) was added to a mixture of 4-(4,4,5,5- tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 H-pyrazole (1 .00 g, 5.15 mmol) and caesium carbonate (3.49 mg, 10.72 mmol) in dry N,N-dimethylformamide (20 mL) at 0°O. After stirring for 30 mm the ice-water bath was removed. The reaction mixture was stirred at room temperature overnight. The reaction mixture was diluted with ethyl acetate (150 mL) and washed with brine(3x100 mL). The organic layer was dried with sodium sulfate and concentrated in vacuo. Purification by flash column chromatography (Method L7; 12 g; heptane, 10percent-30percent ethyl acetate) afforded 0.74 g (2.92 mmol; 57percent of theory) of the title compound.GO-MS (Method L9): R1 = 4.21 mm; m/z = 251 MH NMR (300 MHz, Ohloroform-d, Method M2) 6 7.79 (s, 1 H), 7.76 (s, 1 H), 4.29 (t, J = 5.3 Hz,2H), 3.75 (t, J = 5.3 Hz, 2H), 3.32 (s, 3H), 1.31 (s, 12H).
56%
Stage #1: With sodium hydride In N,N-dimethyl-formamide for 0.25 h;
Stage #2: at 80℃; for 1 h; Microwave irradiation
General procedure: Preparation 122: 1 -(2-Methoxyethyl)-4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 H- Method H NaH (60percent, 83 mg) was added to a solution of 4-(4,4,5,5-tetramethyl-1 ,3,2- dioxaborolan-2-yl)-1 - -pyrazole (204 mg, 1 .05 mmol) in DMF (4 mL). After stirring for 15 minutes, 1 -bromo-2-methoxyethane (175 mg, 1 .26 mmol) in DMF (1 mL) was added. The resulting solution was stirred at 80°C under microwave irradiation for 60 minutes. The reaction mixture was diluted with brine and extracted with EtOAc. The combined organic layers were washed with water, dried with Na2S04j and concentrated in vacuo to afford the title compound as a yellow oil that was used directly in the next step (148 mg, 56percent). 1 H NMR (500 MHz, CDCI3): δ 7.80 (d, J = 0.7 Hz, 1 H), 7.77 (d, J = 0.7 Hz, 1 H), 4.31 (t, = 5.3 Hz, 2H), 3.76 (t, J = 5.3 Hz, 2H), 3.33 (s, 3H), 1.32 (s, 12H). LCMS (ESI) Rt = 2.17 minutes MS m/z 253 [M+H]+
26%
Stage #1: With sodium hydride In N,N-dimethyl-formamide; mineral oil at 20℃; for 1 h;
Stage #2: at 0 - 20℃; for 1 h;
To a solution of 4-(tetramethyl-1 ,3, 2-dioxaborolan-2-yl)-1H-pyrazole (1 .00 g, 5.1 mmol) in DMF (5 mL) was added sodium hydride (245 mg of a 60percent dispersion in mineral oil, 6.1 mmol) at room temperature. The mixture was then stirred at room temperature for 60 minutes. The mixture was cooled to 0 ° C and 2-bromoethyl methyl ether (0.72 mL, 7.7 mmol) was added drop wise via syringe. After complete addition, the mixture was allowed to warm to room temperature and stirred for an hour prior to addition of ethyl acetate (70 mL) and water (30 mL). The organic layer was separated, washed with water (2 x 30 mL) and brine (30 mL), dried (Na2S04), filtered and concentrated at reduced pressure. The residue was purified by Biotage Isolera™ chromatography [Biotage SNAP Cartridge KP-Sil 50 g; using a gradient of eluents, 0-50percent EtOAc in heptane] to give the title compound (333 mg, 26percent yield) as a colourless oil. 1H NMR (250 MHz, DMSO-d6) δ [ppm] 7.88 (s, 1 H), 7.57 (s, 1 H), 4.32 - 4.20 (m, 2H), 3.73 - 3.60 (m, 2H), 3.21 (s, 3H), 1 .25 (s, 12H). LCMS (Analytical Method A): Rt = 1 .01 mins, MS (ESIPos): m/z = 253 (M+H)\
20% With potassium hydroxide In ethanol at 50℃; for 76 h; Intermediate 1171 -[2-(Methyloxy)ethyl]-4-(4,4,5,5-tetrameth l-1 ,3,2-dioxaborolan-2-yl)-1 H-pyrazolA solution of 4-(4,4,5,5-tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 H-pyrazole (10 g, 51 .5 mmol) in ethanol (50 mL) was treated with KOH (3.47 g, 61 .8 mmol) and 1 -bromo-2- (methyloxy)ethane (5.81 mL, 61.8 mmol) at room temperature and the resulting mixture was stirred at 50°C under nitrogen for 16 h then cooled to room temeprature. 1 -Bromo-2- (methyloxy)ethane (2 ml_, 21 .3 mmol) was added and the resulting mixture was stirred at 50°C for 60 h then cooled to room temperature. The mixture was filtered through celite and the insoluble were washed with ethanol. The combined filtrate and washings were concentrated in vacuo. Purification of the residue on SP4 using a 100 G silica cartridge (gradient: 0 to 100percent AcOEt in Hexanes) gave 1 -[2-(methyloxy)ethyl]-4-(4,4,5,5- tetramethyl-1 ,3,2-dioxaborolan-2-yl)-1 /-/-pyrazole (2.72 g, 10.25 mmol, 20percent) as a yellow oil. LCMS (method G): Retention time 0.87 min, [M+H]+ = 252.9
20% With potassium hydroxide In ethanol at 50℃; for 66 h; Inert atmosphere A solution of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (10 g, 51.5 mmol) in ethanol (50 mL) was treated with KOH (3.47 g, 61.8 mmol) and 1-bromo-2-(methyloxy)ethane (5.81 mL, 61.8 mmol) at room temperature and the resulting mixture was stirred at 50° C. under nitrogen for 16 h then cooled to room temperature. 1-Bromo-2-(methyloxy)ethane (2 mL, 21.3 mmol) was added and the resulting mixture was stirred at 50° C. for 60 h then cooled to room temperature. The mixture was filtered through celite and the insoluble were washed with ethanol. The combined filtrate and washings were concentrated in vacuo. Purification of the residue on SP4 using a 100 G silica cartridge (gradient: 0 to 100percent AcOEt in Hexanes) gave 1-[2-(methyloxy)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole (2.72 g, 10.25 mmol, 20percent) as a yellow oil. LCMS (method G): Retention time 0.87 min, [M+H]+=252.9
25.4 g With caesium carbonate In N,N-dimethyl-formamide at 80℃; 4-(4,4,5,5-Tetramethyl-[1 ,3,2]clioxaborolan-2-yl)-1 H-pyrazole (19.4 g, 0.10 mol), 1- bromo-2-methoxy-ethane (14.18 ml, 0.15 mol), and caesium carbonate (32.58 g, 0.1 mol) are dissolved in DMF (200 ml). The suspension is stirred for 16 h at 80°C, filtered and the solvent is removed in vacuum. The residue is treated with tert-butyl methyl ether (200 ml), filtered over Celite and then the solvent is removed in vacuum; yield: 25.4 g 1-(2-methoxy-ethyl)-4-(4,4,5,5-tetramethyl-[1,3,2]dioxa- borolan-2-yl)-1H-pyrazole; HPLC/MS: 1.82 min, [M+H] = 253.
1.31 g With caesium carbonate In acetonitrile at 50℃; Inert atmosphere 1H-pyrazole-4-boronic acid pinacol ester (1.0 g, 5.155 mmol),2-Bromoethyl methyl ether (0.788 g, 5.669 mmol)And cesium carbonate (5.04 g, 15.469 mmol) were dissolved in acetonitrile (20 mL),The mixture was stirred under nitrogen at 50 ° C overnight,filter,Concentrate to dryness to give 1- (2-methoxyethyl) -1H-pyrazole-4-boronic acid pinacol ester (1.310 g).

Reference: [1] Patent: WO2014/151106, 2014, A1, . Location in patent: Paragraph 00179
[2] Patent: WO2011/51342, 2011, A1, . Location in patent: Page/Page column 95
[3] Patent: US2011/269752, 2011, A1, . Location in patent: Page/Page column 42
[4] Patent: WO2017/178416, 2017, A1, . Location in patent: Page/Page column 115
[5] Patent: WO2014/37751, 2014, A1, . Location in patent: Paragraph 00416-00418
[6] Patent: WO2018/114786, 2018, A1, . Location in patent: Page/Page column 142
[7] Patent: WO2011/54841, 2011, A1, . Location in patent: Page/Page column 106-107
[8] Patent: US2012/208798, 2012, A1, . Location in patent: Page/Page column 48
[9] Patent: WO2010/19899, 2010, A1, . Location in patent: Page/Page column 154
[10] Patent: WO2010/75270, 2010, A1, . Location in patent: Page/Page column 169
[11] Patent: WO2012/167423, 2012, A1, . Location in patent: Page/Page column 35-36
[12] Patent: WO2013/117285, 2013, A1, . Location in patent: Page/Page column 82; 83
[13] Patent: US2014/121200, 2014, A1, . Location in patent: Paragraph 0166; 0167
[14] Patent: CN107312005, 2017, A, . Location in patent: Paragraph 0474; 0475; 0476; 0477
  • 24
  • [ 35344-95-7 ]
  • [ 6482-24-2 ]
  • [ 304693-70-7 ]
YieldReaction ConditionsOperation in experiment
65% With caesium carbonate In N,N-dimethyl-formamide at 60℃; To a solution of lH-pyrazole-4-carbaldehyde (500 mg, 5.20 mmol) in DMF (20 mL) was added l-bromo-2-methoxyethane (713 mg, 5.2 mmol) and CS2CO3 (3.40 g, 10.4 mmol). After stirring at 60 °C overnight, water (20 mL) was added to the mixture and the mixture was extracted with EtOAc (50 ml x 3). The organic phase was washed with brine, dried over Na2S04 and concentrated to yield intermediate 50 (520 mg, 65percent> yield).
55% With caesium carbonate In acetonitrile for 2 h; Reflux 1H-pyrazole-4-carbaldehyde (0.5 g; 5.2 mmol) and cesium carbonate (3.39 g; 10.4mmol) were diluted in ACN (10 mL). Then, 2-bromoethyl methyl ether (0.636 mL; 6.77 mmol) was added and the reaction mixture was refluxed for 2 hours. The reaction mixture was partitionned between a saturated solution of NaHCO3 and EtOAc. The organic layer was separated, dried over MgSO4, filtered and concentrated.The residue was purified by silica gel chromatography (irregular Si02, 120 g, DCM/MeOH: 100/0 to 95/5). The fractions containing the product were mixed andconcentrated to afford 439 mg (55percent) of intermediate 35.
Reference: [1] Patent: WO2018/50684, 2018, A1, . Location in patent: Page/Page column 68
[2] Patent: WO2018/50686, 2018, A1, . Location in patent: Page/Page column 72; 73
  • 25
  • [ 2075-46-9 ]
  • [ 6482-24-2 ]
  • [ 948570-74-9 ]
Reference: [1] Patent: WO2014/7951, 2014, A2, . Location in patent: Page/Page column 241
  • 26
  • [ 2075-46-9 ]
  • [ 6482-24-2 ]
  • [ 948570-75-0 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In acetonitrile at 80℃; for 4 h; [0223j To a mixture of 4-nitro-1H-pyrazole (113 mg, 1 mmol, 1.0 eq) in CH3CN (5 mL), 1-bromo-2-methoxyethane (138 mg, 1 mmol, 1.0 equiv) and K2C03 (276 mg, 2 mmol, 2.0 equiv) was added. The mixture was stirred at 80 °C for 4 h. After diluted with EtOAc (100 mL), the mixture was washed with water (50 mL x 2). The organic layer was concentrated and purified by silica gel column (petroleum ether/EtOAc = 10 : 1) to give 1-(2-methoxyethyl)-4-nitro-1H- pyrazole (170 mg, yield: 100percent) as a colorless oil. ESI-MS (M+H): 172.1. ‘H NMR (400 MHz, CDC13) (5: 8.23 (s, 1H), 8.07 (s, 1H), 4.31 (t, J= 5.2 Hz, 2H), 3.74 (t, J= 5.2 Hz, 2H), 3.35 (s, 3H).
97% With potassium carbonate In acetonitrile at 90℃; for 5 h; To a solution of 4-nitro-1H-pyrazole 12 (1.70 g, 15.03 mmol) in CH3CN (50 mL) was added K2C03 (3.11 g, 22.53 mmol) followed by addition of 1-bromo-2- methoxy-ethane (2.5 g, 18.0 mmol) at room temperature. The reaction mixture was heated to 90°C for 5 h. After completion of reaction (monitored by TLC), the solvent was evaporated, added water and extracted with EtOAc (3 x 200 mL). the combined organics was washed with water, brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford 2.50 g (97percent yield) of the title compound 16 as colorless liquid. 1H NMR (400 MHz, DMDO-d6): 3 8.85 (s, 1H), 8.27 (s, 1H), 4.36-4.33 (t, 2H), 3.77-3.72 (t, 2H), 3.23 (s, 3H). MS: 172.11 (M+H).
76% With potassium carbonate In acetonitrile at 60℃; for 6 h; A mixture of 4-nitro-1H-pyrazole (1 equiv), 1-bromo-2-methoxyethane (1.05 equiv), potassium carbonate (1.5 equiv) and acetonitrile (0.44 M) was stirred and heated to 60° C. for 6 h. The resultant mixture was evaporated and the residue was purified by flash chromatography (2.5percent MeOH in DCM) to afford the desired product as a yellow solid (76percent yield). 1H NMR (400 MHz, CHLOROFORM-d1) δ ppm 8.25 (s, 1H), 8.08 (s, 1H), 4.34-4.31 (t, J=4.8 Hz, 2H), 3.77-3.74 (t, J=4.8 Hz, 2H), 3.37 (s, 3H)
Reference: [1] Patent: WO2015/89337, 2015, A1, . Location in patent: Paragraph 0223
[2] Patent: WO2015/25197, 2015, A1, . Location in patent: Paragraph 00078
[3] Patent: US2014/200206, 2014, A1, . Location in patent: Paragraph 0339
[4] Patent: WO2007/99326, 2007, A1, . Location in patent: Page/Page column 104
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 6482-24-2 ]

Aliphatic Chain Hydrocarbons

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.92

Chemical Structure| 57602-02-5

[ 57602-02-5 ]

1,14-Dibromo-3,6,9,12-tetraoxatetradecane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.75

Chemical Structure| 7252-83-7

[ 7252-83-7 ]

2-Bromo-1,1-dimethoxyethane

Similarity: 0.67

Chemical Structure| 36865-41-5

[ 36865-41-5 ]

1-Bromo-3-methoxypropane

Similarity: 0.63

Bromides

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.92

Chemical Structure| 57602-02-5

[ 57602-02-5 ]

1,14-Dibromo-3,6,9,12-tetraoxatetradecane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.75

Chemical Structure| 39267-79-3

[ 39267-79-3 ]

3-Bromooxetane

Similarity: 0.75

Chemical Structure| 7252-83-7

[ 7252-83-7 ]

2-Bromo-1,1-dimethoxyethane

Similarity: 0.67

Ethers

Chemical Structure| 5414-19-7

[ 5414-19-7 ]

1-Bromo-2-(2-bromoethoxy)ethane

Similarity: 0.92

Chemical Structure| 57602-02-5

[ 57602-02-5 ]

1,14-Dibromo-3,6,9,12-tetraoxatetradecane

Similarity: 0.86

Chemical Structure| 54149-16-5

[ 54149-16-5 ]

2-(2-Bromoethoxy)propane

Similarity: 0.75

Chemical Structure| 7252-83-7

[ 7252-83-7 ]

2-Bromo-1,1-dimethoxyethane

Similarity: 0.67

Chemical Structure| 36865-41-5

[ 36865-41-5 ]

1-Bromo-3-methoxypropane

Similarity: 0.63

; ;